Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists
- PMID: 20709559
- PMCID: PMC2941879
- DOI: 10.1016/j.bmc.2010.07.052
Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists
Abstract
The octahydrobenzo[h]isoquinoline scaffold is of interest as a conformationally-restricted phenethylamine that may be useful for constructing biologically active products. Surprisingly, however, no tractable synthesis of this ring system has been reported. We now describe a facile method for obtaining this framework, and illustrate that our approach is easily amenable to substitutions at the 5-position. Importantly, we demonstrate that the 7,8-dihydroxy-5-phenyl-substituted ligand is an extremely potent, high-affinity, full D1 dopamine receptor-selective agonist.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
Figures





Similar articles
-
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.J Med Chem. 2006 Nov 16;49(23):6848-57. doi: 10.1021/jm0604979. J Med Chem. 2006. PMID: 17154515
-
Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.Eur J Med Chem. 2012 Feb;48:97-107. doi: 10.1016/j.ejmech.2011.11.039. Epub 2011 Dec 3. Eur J Med Chem. 2012. PMID: 22204903 Free PMC article.
-
9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.J Med Chem. 1996 Jan 19;39(2):549-55. doi: 10.1021/jm950707+. J Med Chem. 1996. PMID: 8558526
-
Dihydrexidine--the first full dopamine D1 receptor agonist.CNS Drug Rev. 2004 Fall;10(3):230-42. doi: 10.1111/j.1527-3458.2004.tb00024.x. CNS Drug Rev. 2004. PMID: 15492773 Free PMC article. Review.
-
Dopamine D1 receptor ligands: where are we now and where are we going.Med Res Rev. 2009 Mar;29(2):272-94. doi: 10.1002/med.20130. Med Res Rev. 2009. PMID: 18642350 Review.
Cited by
-
Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.ChemMedChem. 2012 Mar 5;7(3):483-94, 338. doi: 10.1002/cmdc.201100546. Epub 2012 Feb 7. ChemMedChem. 2012. PMID: 22315216 Free PMC article.
-
Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.ChemMedChem. 2011 Jun 6;6(6):1024-40. doi: 10.1002/cmdc.201100010. Epub 2011 Apr 28. ChemMedChem. 2011. PMID: 21538900 Free PMC article.
-
Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.Bioorg Med Chem. 2012 Nov 1;20(21):6366-74. doi: 10.1016/j.bmc.2012.08.058. Epub 2012 Sep 8. Bioorg Med Chem. 2012. PMID: 23018094 Free PMC article.
References
-
- Brewster WK, Nichols DE, Riggs RM, Mottola DM, Lovenberg TW, Lewis MH, Mailman RB. J Med Chem. 1990;33:1756–1764. - PubMed
-
- Cannon JG, Hatheway GJ. J Med Chem. 1976;19:987–993. - PubMed
-
- Cannon JG, Suarez-Gutierrez C, Lee T, Long JP, Costall B, Fortune DH, Naylor RJ. J Med Chem. 1979;22:341–347. - PubMed
-
- Cannon JG, Lee T, Goldman HD, Long JP, Flynn JR, Verimer T, Costall B, Naylor RJ. J Med Chem. 1980;23:1–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information